S
Suheil J. Muasher
Researcher at Duke University
Publications - 184
Citations - 8248
Suheil J. Muasher is an academic researcher from Duke University. The author has contributed to research in topics: In vitro fertilisation & Pregnancy. The author has an hindex of 50, co-authored 183 publications receiving 7870 citations. Previous affiliations of Suheil J. Muasher include George Washington University & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome
Richard T. Scott,James P. Toner,Suheil J. Muasher,Sergio Oehninger,Shirley M. Robinson,Zev Rosenwaks +5 more
TL;DR: Cycle day 3 FSH levels are predictive of pregnancy outcome and stimulation characteristics in IVF, and may be useful in counseling patients.
Journal ArticleDOI
Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age
TL;DR: Follicle-stimulating hormone level was a better predictor than age for all outcome variables examined and remained a significant predictor after accounting for age, etiology of infertility, and semen quality.
Journal ArticleDOI
The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome.
Suheil J. Muasher,Sergio Oehninger,Simonetta Simonetti,James F. Matta,Linda M. Ellis,Hung-Ching Liu,Georgeanna Seegar Jones,Zev Rosenwaks +7 more
TL;DR: It is concluded that basal serum gonadotropin levels can distinguish different populations of IVF patients who tend to behave differently in terms of E2 response, oocytes obtained and transferred, and pregnancy rates and outcome.
Journal ArticleDOI
Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles.
Ryan G. Steward,Lan Lan,Anish A. Shah,Jason S. Yeh,Thomas M Price,James M. Goldfarb,Suheil J. Muasher +6 more
TL;DR: Retrieval of >15 oocytes significantly increases OHSS risk without improving LB rate in fresh autologous IVF cycles, and less aggressive stimulation protocols should be considered, especially in high-responders, to optimize outcomes.
Journal ArticleDOI
Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation.
Margo R. Fluker,James A. Grifo,Arthur Leader,Michael J. Levy,David R. Meldrum,Suheil J. Muasher,John S. Rinehart,Zev Rosenwaks,Richard T. Scott,William B. Schoolcraft,Daniel B. Shapiro,Keith Gordon +11 more
TL;DR: Compared with leuprolide acetate, ganirelix therapy has a shorter duration and fewer injections but produces a similar pregnancy rate and is effective, safe, and well tolerated.